6929 — OrbusNeich Medical group Balance Sheet
0.000.00%
- HK$3.35bn
- HK$1.55bn
- $164.10m
- 78
- 70
- 78
- 91
Annual balance sheet for OrbusNeich Medical group, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15.1 | 176 | 248 | 256 | 249 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 27.2 | 27.1 | 34.8 | 46.4 | 52.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 74.5 | 235 | 314 | 348 | 361 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.6 | 13.4 | 13 | 18.5 | 27.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 104 | 269 | 351 | 410 | 431 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 55.5 | 16.4 | 23.8 | 35.6 | 30.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 68.8 | 85.4 | 28.5 | 41.7 | 37.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 34.9 | 183 | 323 | 368 | 393 |
| Total Liabilities & Shareholders' Equity | 104 | 269 | 351 | 410 | 431 |
| Total Common Shares Outstanding |